Related Experiment Videos
[Sarcoma of the uterus. A retrospective clinical study of 56 cases]
Ugeskrift for Laeger
|November 11, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
European journal of gynaecological oncology·1994
Plasma oestrogens in postmenopausal women with endometrial cancer.
British journal of obstetrics and gynaecology·1993
Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·1993
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Gynecologic and obstetric investigation·1992
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Gynecologic and obstetric investigation·1990
[Myelin oligodendrocyte glycoprotein antibody-associated disease].
Ugeskrift for laeger·2026
[Clinical pharmacogenetics and the use of biobanks].
Ugeskrift for laeger·2026
[Cutaneous myiasis].
Ugeskrift for laeger·2026
[When radiology does not rule out intracranial hypertension].
Ugeskrift for laeger·2026
[Intracranial hypotension].
Ugeskrift for laeger·2026
[Large macrocystic lymphatic malformation in a newborn].
Ugeskrift for laeger·2026
Clinical and Electrodiagnostic Characteristics of COVID-19-Associated Guillain-Barré Syndrome: A Multicenter Study.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Cost-Effectiveness and Clinical Utility of a Retinal Cardiovascular AI-Guided Strategy for Statin Initiation: A South Korean Multicenter Prospective Study.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026